8URO image
Deposition Date 2023-10-26
Release Date 2024-10-30
Last Version Date 2025-07-16
Entry Detail
PDB ID:
8URO
Keywords:
Title:
Crystal structure of IgG1-Fc fragment (E382S) in complex with Corynebacterial ENGase CU43 (D187A-E189A)
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
3.62 Å
R-Value Free:
0.36
R-Value Work:
0.33
R-Value Observed:
0.33
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Corynebacterial protease CP40
Mutagens:D187A, E189A
Chain IDs:A, D
Chain Length:415
Number of Molecules:2
Biological Source:Corynebacterium ulcerans
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Immunoglobulin gamma-1 heavy chain
Mutagens:E382S
Chain IDs:B, C, E, F
Chain Length:232
Number of Molecules:4
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
The mechanistic basis for interprotomer deglycosylation of antibodies by corynebacterial IgG-specific endoglycosidases.
Nat Commun 16 6147 6147 (2025)
PMID: 40610417 DOI: 10.1038/s41467-025-60986-w

Abstact

Corynebacterium diphtheriae clade species secrete single-domain endo-β-N-acetylglucosaminidases (ENGases) that specifically bind to human IgG antibodies and hydrolyze their N297-linked glycans. Here, we define the molecular mechanisms of IgG-specific deglycosylation for the entire family of corynebacterial IgG-specific ENGases, including but not limited to CU43 and CM49. By solving the crystal structure of CU43 in a 1:1 complex with the IgG1 Fc region, combined with targeted and saturation mutagenesis analysis and activity measurements using engineered antibodies, we establish an inter-protomeric mechanism of recognition and deglycosylation of IgG antibodies. Using in silico modeling, small-angle X-ray scattering and saturation mutagenesis we determine that CM49 uses a unique binding site on the Fc region, to process N297-linked glycans. Moreover, we demonstrate that CU43 treatment is highly effective in abrogating Fc effector functions in humanized mouse models, while preserving the neutralizing capacity of anti-influenza IgG antibodies, thereby conferring protection against lethal influenza challenge.

Legend

Protein

Chemical

Disease

Primary Citation of related structures